APA (7th ed.) Citation

Y, W., Y, A., Y, H., K, K., R, I., & T, I. (2018). Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: Exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Watanabe, Asami Y, Hirano Y, Kuribayashi K, Itamura R, and Imaeda T. Factors Impacting the Efficacy of Venlafaxine Extended Release 75–225 Mg/day in Patients with Major Depressive Disorder: Exploratory Post Hoc Subgroup Analyses of a Randomized, Double-blind, Placebo-controlled Study in Japan. Dove Medical Press, 2018.

MLA (8th ed.) Citation

Y, Watanabe, et al. Factors Impacting the Efficacy of Venlafaxine Extended Release 75–225 Mg/day in Patients with Major Depressive Disorder: Exploratory Post Hoc Subgroup Analyses of a Randomized, Double-blind, Placebo-controlled Study in Japan. Dove Medical Press, 2018.